Estrogen-progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia.
Recurrent gastrointestinal bleeding ceased after the institution of estrogen-progesterone therapy in a patient with gastrointestinal angiodysplasia without chronic renal failure. The patient did have aortic stenosis and mitral insufficiency murmurs. A therapeutic trial of conjugated estrogen should be considered in patients with recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia after the use of therapeutic endoscopy and/or surgery.
Granieri
R
R
Mazzulla
J P
JP
Yarborough
G W
GW
D000368:Aged; D001808:Blood Vessels / Q000002:abnormalities*; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D004064:Digestive System / Q000098:blood supply*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008656:Mestranol / Q000627:therapeutic use*; D009641:Norethynodrel / Q000627:therapeutic use*; D012008:Recurrence
D003277:Contraceptives, Oral, Combined; C008124:Infecundin; D009641:Norethynodrel; D008656:Mestranol